Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.6 USD | +0.04% | +1.90% | -24.76% |
Business Summary
Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Number of employees: 382
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Recombinant Human C1 Esterase Inhibitor
100.0
%
| 196 | 100.0 % | 227 | 100.0 % | +15.98% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.5
%
| 190 | 97.3 % | 221 | 97.5 % | +16.17% |
Europe and Rest of World
2.5
%
| - | - | 6 | 2.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 12/10/08 |
Jeroen Wakkerman
DFI | Director of Finance/CFO | 55 | 15/11/20 |
Anurag Relan
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Mireille Sanders
COO | Chief Operating Officer | 56 | 30/04/19 |
Compliance Officer | 60 | 31/03/20 | |
Michael Levitan
IRC | Investor Relations Contact | 66 | - |
Stephen Toor
PRN | Corporate Officer/Principal | 52 | 14/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Pykett
BRD | Director/Board Member | 60 | 10/12/20 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 18/05/21 |
Sijmen de Vries
CEO | Chief Executive Officer | 65 | 12/10/08 |
Steven Baert
BRD | Director/Board Member | 50 | 31/03/21 |
Deborah Jorn
BRD | Director/Board Member | 66 | 21/05/19 |
Barbara Yanni
BRD | Director/Board Member | 69 | 10/12/20 |
Director/Board Member | 58 | 18/05/21 | |
Richard Peters
CHM | Chairman | 61 | 24/09/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 673,441,363 | 657,631,963 ( 97.65 %) | 0 | 97.65 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.13% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.55% | 246B | |
0.00% | 225B | |
+10.47% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- PHARM Stock
- PHAR Stock
- Company Pharming Group N.V.